Patients 60 Years and Older Suffering From Mandibular Fractures Registry

Overview

Approximately 200 of patients of 60 years or older who present a mandibular fracture will be enrolled in this registry. All patients will be treated and followed up according to the local standard (routine) of care at around 2 weeks, 6 weeks, 3 months and 6 months after treatment.

Full Title of Study: “International, Multicenter, Prospective Registry to Collect Data in Patients 60 Years and Older Suffering From Mandibular Fractures”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: January 2023

Detailed Description

Patients of 60 years or older who present a mandibular fracture will be enrolled in this registry. All patients will be treated (surgical or non-surgical) and followed up according to the local standard (routine) of care at around 2 weeks, 6 weeks, 3 months and 6 months after treatment. Data collection will include patient and fracture details, treatment details, functional, clinical and patient-reported outcomes and anticipated or procedure- and implant-related adverse events (i.e. complications). Radiographs and/or other images (e.g. CT scan) taken as per standard of care will be collected within the registry. Primary objectives are to obtain epidemiological data and describe the most common mandibular fracture patterns in older patients, to explore the relationship(s) between the treatment of mandibular fractures and its outcome in older patients, to identify risk factors and initiating factors of elderly related to mandible fracture events and to describe concomitant fractures associated with mandibular fractures in older patients.

Interventions

  • Procedure: Surgery
    • Surgical fracture treatment
  • Other: Non-Surgical fracture treatment
    • Non-Surgical fracture treatment

Arms, Groups and Cohorts

  • Mandibular Fracture
    • Elderly patients of > 60 years who present a mandibular fracture Surgery or Non-surgical fracture treatment will be applied according to routine clinical practice

Clinical Trial Outcome Measures

Primary Measures

  • Patient-reported outcome
    • Time Frame: Baseline (preinjury)/ 2 weeks / 6 weeks / 3 months / 6 months
    • Change in Geriatric/general Oral Self Assessment Index (GOHAI) over the follow up period: Self-reported measurement to describe three hypothetical dimensions 1) physical function, 2) psychosocial function and 3) pain and/or discomfort. It consisted of 12 items evaluated using a 5-point Likert from “never” to “always” in which higher scores indicated better outcomes.

Participating in This Clinical Trial

Inclusion Criteria

  • Age > 60 years at the time of the injury – Diagnosis of any kind of mandibular fracture – Informed consent obtained, i.e.: – Ability to understand the content of the patient information/ informed consent form (ICF) – Willingness and ability to participate in the clinical investigation according to the Registry Plan (RP) – Signed and dated EC/IRB approved written informed consent OR For patients who are not able to provide independent written informed consent: Written consent provided according to defined and IRB/EC approved procedures Exclusion Criteria:

  • Patients with previous history of mandibular fractures or mandibular defects treated surgically – Participation in any other medical device or medicinal product study within the previous months that could influence bone healing and the results of the present study in the opinion of the treating physician

Gender Eligibility: All

Minimum Age: 60 Years

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • AO Clinical Investigation and Publishing Documentation
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Risto Kontio, Prof., Principal Investigator, Department of Oral and Maxillofacial Surgery, Helsinki University Hospital
  • Overall Contact(s)
    • Joffrey Baczkowski, +41 44 200 24 31, joffrey.baczkowski@aofoundation.org

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.